EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Genetic and functional analyses of SPTLC1 in juvenile amyotrophic lateral sclerosis

So Okubo, Hiroya Naruse, Hiroyuki Ishiura, Atsushi Sudo, Kayoko Esaki, Jun Mitsui, Takashi Matsukawa, Wataru Satake, Peter Greimel, Nanoka Shingai, Yasushi Oya, Takeo Yoshikawa und 2 weitere

Journal of Neurology · 2025-01 · 272 (1)

DOI: 10.1007/s00415-024-12776-5 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Neurology, online erschienen am 12.12.2024. Verfasst von So Okubo und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Graduate School of Medicine, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo, 113-8655, Japan. Hauptthemen laut MEDLINE: Amyotrophic Lateral Sclerosis, Serine C-Palmitoyltransferase. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministry of Health, Labour and Welfare, Japan Agency for Medical Research and Development, Japan Society for the Promotion of Science.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder of the motor system. Pathogenic variants in SPTLC1 , encoding a subunit of serine palmitoyltransferase, cause hereditary sensory and autonomic neuropathy type 1 (HSAN1), and have recently been associated with juvenile ALS. SPTLC1 variants associated with ALS cause elevated levels of sphinganines and ceramides. Reports on ALS associated with SPTLC1 remain limited. This study aimed to investigate the frequency of SPTLC1 variants in ALS and relevant clinical characteristics.

Methods

We analyzed whole-exome and whole-genome sequence data from 40 probands with familial ALS and 413 patients with sporadic ALS without previously identified causative variants. Reverse transcription polymerase chain reaction (RT-PCR) analysis and droplet digital PCR (ddPCR) were used to assess splicing and mosaicism, respectively. Plasma sphingolipid levels were quantified to analyze biochemical consequences.

Results

The heterozygous c.58G>A, p.Ala20Thr variant was identified in a 21-year-old Japanese female patient presenting with symmetric weakness which slowly progressed over 15 years. RT-PCR analysis showed no splice defects. Plasma sphingolipid levels in the patient were significantly increased compared to her asymptomatic parents. ddPCR revealed that the asymptomatic father harbored a mosaic variant with 17% relative mutant allele abundance in peripheral blood leukocytes.

Conclusions

We identified a pathogenic c.58G>A, p.Ala20Thr SPTLC1 variant in a patient with juvenile ALS, likely inherited from an asymptomatic parent with mosaicism. Lipid analysis results are consistent with previous findings on SPTLC1 -associated ALS. Further studies are necessary to determine the clinical effect of mosaic variants of SPTLC1 .

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Amyotrophic Lateral SclerosisSerine C-PalmitoyltransferaseAdolescentAdultAgedFemaleHumansMaleMiddle AgedYoung AdultMutationPedigreeSphingolipids

Stichwörter der Autor:innen

SPTLC1Juvenile amyotrophic lateral sclerosisMosaicismSphingolipids

Substanzen

Serine C-PalmitoyltransferaseSphingolipidsSPTLC1 protein, human

Autor:innen und Institutionen

  • Department of Neurology, Graduate School of Medicine, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo, 113-8655, Japan.
  • Department of Neurology, Graduate School of Medicine, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo, 113-8655, Japan. naruse.hiroya@mail.u-tokyo.ac.jp.
  • Department of Precision Medicine Neurology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan. naruse.hiroya@mail.u-tokyo.ac.jp.
  • Department of Neurology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan.
  • Department of Biotechnology and Life Sciences, Faculty of Biotechnology and Life Sciences, Sojo University, Kumamoto, Japan.
  • Department of Precision Medicine Neurology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.

Förderung

  • Ministry of Health, Labour and Welfare
  • Japan Agency for Medical Research and Development
  • Japan Society for the Promotion of Science
  • RIKEN
  • The University of Tokyo

Zitieren

APA

Okubo, S., Naruse, H., Ishiura, H., Sudo, A., Esaki, K., Mitsui, J., Matsukawa, T., Satake, W., Greimel, P., Shingai, N., Oya, Y., Yoshikawa, T., Tsuji, S., & Toda, T. (2025). Genetic and functional analyses of SPTLC1 in juvenile amyotrophic lateral sclerosis. Journal of Neurology, 272(1). https://doi.org/10.1007/s00415-024-12776-5

Vancouver

Okubo S, Naruse H, Ishiura H, Sudo A, Esaki K, Mitsui J, et al. Genetic and functional analyses of SPTLC1 in juvenile amyotrophic lateral sclerosis. Journal of Neurology. 2025;272(1). doi:10.1007/s00415-024-12776-5

BibTeX
@article{Okubo2025,
  author = {Okubo, So and Naruse, Hiroya and Ishiura, Hiroyuki and Sudo, Atsushi and Esaki, Kayoko and Mitsui, Jun and Matsukawa, Takashi and Satake, Wataru and Greimel, Peter and Shingai, Nanoka and Oya, Yasushi and Yoshikawa, Takeo and Tsuji, Shoji and Toda, Tatsushi},
  title = {Genetic and functional analyses of SPTLC1 in juvenile amyotrophic lateral sclerosis},
  journal = {Journal of Neurology},
  year = {2025},
  volume = {272},
  number = {1},
  doi = {10.1007/s00415-024-12776-5}
}
Kostenlos starten →